Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
Queensland Health
Deloitte
Cantor Fitzgerald
Cerilliant
Mallinckrodt
US Department of Justice
Daiichi Sankyo

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021119

« Back to Dashboard

NDA 021119 describes VISUDYNE, which is a drug marketed by Valeant Luxembourg and is included in one NDA. It is available from two suppliers. Additional details are available on the VISUDYNE profile page.

The generic ingredient in VISUDYNE is verteporfin. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the verteporfin profile page.
Summary for 021119
Tradename:VISUDYNE
Applicant:Valeant Luxembourg
Ingredient:verteporfin
Patents:0
Pharmacology for NDA: 021119
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity
Suppliers and Packaging for NDA: 021119
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VISUDYNE verteporfin INJECTABLE;INJECTION 021119 NDA Valeant Pharmaceuticals North America LLC 0187-5600 N 0187-5600-15
VISUDYNE verteporfin INJECTABLE;INJECTION 021119 NDA QLT Ophthalmics, Inc. 50236-001 E 50236-001-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength15MG/VIAL
Approval Date:Apr 12, 2000TE:RLD:Yes

Expired US Patents for NDA 021119

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
McKinsey
Express Scripts
UBS
Baxter
McKesson
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.